Dia Spectr
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cryer, P. E.
Right arrow Articles by Childs, B. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cryer, P. E.
Right arrow Articles by Childs, B. P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Spectrum 15:20-27, 2002
© American Diabetes Association ®, Inc., 2002

Negotiating the Barrier of Hypoglycemia in Diabetes

Philip E. Cryer, MD and Belinda P. Childs, ARNP, MN, CDE

Hypoglycemia is the limiting factor in the glycemic management of diabetes. It is a barrier to quality of life and even survival in the short term and to true glycemic control, with its established microvascular and potential macrovascular benefits, in the long term. Although it is possible to both improve glycemic control and minimize the risk of hypoglycemia in many patients with currently available regimens—by applying the principles of aggressive therapy and practicing hypoglycemia risk reduction—people with diabetes need treatment methods that provide glucose-regulated insulin secretion or replacement if euglycemia is to be maintained safely over a lifetime of diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
The Diabetes EducatorHome page
G. Spollett
Insulin Devices: Addressing Barriers to Insulin Therapy With the Ideal Pen
The Diabetes Educator, November 1, 2008; 34(6): 957 - 967.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
V. J. Briscoe and S. N. Davis
Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management
Clin. Diabetes, July 1, 2006; 24(3): 115 - 121.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Davies, F. Storms, S. Shutler, M. Bianchi-Biscay, R. Gomis, and for the AT.LANTUS Study Group
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes: Comparison of two treatment algorithms using insulin glargine
Diabetes Care, June 1, 2005; 28(6): 1282 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. E. Cryer, S. N. Davis, and H. Shamoon
Hypoglycemia in Diabetes
Diabetes Care, June 1, 2003; 26(6): 1902 - 1912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.